A Novel Specific Application of Pyruvate Protects the Mouse Retina against White Light Damage: Differential Stabilization ofHIF-1α andHIF-2α
Authors:
- 1 May 2011
- journal article
- research article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 52 (6) , 3112-3118
Abstract
Purpose.: To mimic hypoxia preconditioning by a novel specific pyruvate treatment and to study its retinal protection against white light damage. Methods.: Six-to-eight-week-old BALB/c mice were exposed to strong white light calculated to produce photoreceptor degeneration. Some were given injections of pyruvate in a preordained protocol because evidence exists that proves pyruvate can affect the concentration of hypoxia inducible factor (HIF). Western blotting and real-time PCR were used to determine the concentration of proteins and mRNAs in retinas. Morphology was analyzed with toluidine blue staining and was plotted using a spidergraph. A free nucleosome cell death assay was used to examine apoptosis. Retina explant cultures were used to investigate the background mechanism. Results.: Pyruvate administration stabilized hypoxia inducible factor (HIF)-1α but not HIF-2α. Expression of the downstream genes hemoxygenase-1 and erythropoietin mirrored the changes of the two HIFs, respectively. Importantly, pyruvate given not only before but also after exposure to light protected photoreceptors against apoptosis. In the retinal explant system, addition or depletion of pyruvate caused only changes of HIF-1α and prolyl hydroxylase (PHD)-2, while HIF-2α and PHD1 were not affected. However, under hypoxic conditions, HIF-2α was stabilized by pyruvate but not HIF-1α. Conclusions.: Pyruvate evoked a hypoxia-like response under normoxic conditions and was retina-protective against strong white light. This response included stabilization of HIF-1α but not HIF-2α. This differential stabilization might be related to the distinct preference of their degrading enzyme of PHD2 and PHD1 in response to pyruvate treatment.Keywords
This publication has 21 references indexed in Scilit:
- HIF Prolyl-4-hydroxylase Interacting Proteins: Consequences for Drug TargetingCurrent Pharmaceutical Design, 2009
- Cellular Signal Transduction of the Hypoxia ResponseThe Journal of Biochemistry, 2009
- Drug Discovery for Overcoming Chronic Kidney Disease (CKD): Prolyl-Hydroxylase Inhibitors to Activate Hypoxia-Inducible Factor (HIF) as a Novel Therapeutic Approach in CKDJournal of Pharmacological Sciences, 2009
- Erythropoietin in heart and vessels: focus on transcription and signalling pathwaysJournal of Thrombosis and Thrombolysis, 2008
- Caspase-1 Ablation Protects Photoreceptors in a Model of Autosomal Dominant Retinitis PigmentosaInvestigative Ophthalmology & Visual Science, 2006
- Role of Hypoxia-Inducible Factor (HIF)-1α versus HIF-2α in the Regulation of HIF Target Genes in Response to Hypoxia, Insulin-Like Growth Factor-I, or Loss of von Hippel-Lindau Function: Implications for Targeting the HIF PathwayCancer Research, 2006
- Effect of desferrioxamine and metals on the hydroxylases in the oxygen sensing pathwayThe FASEB Journal, 2005
- HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degenerationNature Medicine, 2002
- TheRpe65Leu450Met Variation Increases Retinal Resistance Against Light-Induced Degeneration by Slowing Rhodopsin RegenerationJournal of Neuroscience, 2001
- Dimerization, DNA Binding, and Transactivation Properties of Hypoxia-inducible Factor 1Journal of Biological Chemistry, 1996